Proton therapy and helical tomotherapy result in reduced dose deposition to the pancreas in the setting of cranio-spinal irradiation for medulloblastoma: Implications for reduced risk of diabetes mellitus in long-term survivors.
The article discusses research which examines the association of cranio-spinal irradiation (CSI) for medulloblastoma with the development of diabetes mellitus (DM) in long-term survivors. It indicates the potential of proton beam therapy (PBT) and helical tomotherapy (HT) to reduce total dose to pancreas and pancreatic tail in the setting of CSI for medulloblastoma. It reveals that patients receiving central nervous system (CNS) irradiation are at risk for the development of late effects.